News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

European Medicines Evaluation Agency Launches New Safety Probe Into GlaxoSmithKline (GSK)'s Avandia; FDA Also Looking Into Safety Concerns



7/9/2010 7:15:43 AM

LONDON, July 9 (Reuters) - European regulators are launching a new probe into the safety of GlaxoSmithKline Plc's (GSK.L) diabetes pill Avandia, adding to pressure on a medicine that already faces a grilling from U.S. experts next week.

Read at Reuters
Read at USA Today
Read at Wall Street Journal
Read at AP
Read at ABC News


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES